For InvestorsAntares Pharma: Making Medicines Feel Better

Recent News

Information contained in these press releases should be considered accurate only as of the date it was prepared. Information may change over time. Do not assume that the information remains accurate at a later date. Antares Pharma, Inc. is not obligated to update the press releases and information contained in this section of the Company’s website.

29 Nov 2018
Antares Pharma Announces The Commercial Availability Of XYOSTED™ (Testosterone Enanthate ) Injection – A New Treatment For Adult Men Diagnosed With Testosterone Deficiency

27 Nov 2018
Antares Pharma Partner TEVA Announces Commercial Availability of Generic EpiPen

26 Nov 2018
Antares Pharma to Present at the 30th Annual Piper Jaffray Healthcare Conference

09 Nov 2018
Antares Pharma Announces Data Presentation at the 2018 Sexual Medicine Society Scientific Annual Meeting

08 Nov 2018
Antares Pharma to Present at the Jefferies 2018 Global Healthcare Conference

06 Nov 2018
Antares Pharma Reports Third Quarter 2018 Operating and Financial Results

30 Oct 2018
Antares Pharma Reports Third Quarter 2018 Operating and Financial Results

01 Oct 2018
Antares Receives FDA Approval of XYOSTED™ (Testosterone Enanthate) Injection for Testosterone Replacement Therapy in Adult Males

16 Aug 2018
Antares Pharma Announces FDA Approval of Generic Epipen Utilizing Vibex Auto Injector

07 Aug 2018
Antares Pharma Reports Second Quarter 2018 Operating and Financial Results

06 Aug 2018
Antares Pharma Appoints Dr. James Tursi Executive Vice President, Head of Research and Development, Chief Medical Officer

06 Aug 2018
Antares Pharma Enters into a Development Agreement with Pfizer INC.

31 Jul 2018
Antares Pharma To Report Second Quarter 2018 Operating and Financial Results

30 May 2018
Antares Pharma Announces Receipt of Third Installment From Sale of ZOMAJET Needle-Free Delivery System

08 May 2018
Antares Pharma Reports First Quarter 2018 Operating and Financial Results

02 May 2018
Antares Pharma to Present at Deutsche Bank Securities, INC.43rd Annual Health Care Conference

01 May 2018
Antares Pharma to Report First Quarter 2018 Financial and Operating Results

05 Apr 2018
Antares Pharma Provides XYOSTED Regulatory Update

27 Mar 2018
Antares Pharma Provides XYOSTED Regulatory Update

13 Mar 2018
Antares Pharma Reports Fourth Quarter And Full Year 2017 Operating and Financial Results

13 Mar 2018
Antares Pharma Provides Update On The Cowen and Company 38th Annual Healthcare Conference

09 Mar 2018
Antares Pharma to Present at the Cowen and Company 38th Annual Healthcare Conference

06 Mar 2018
Antares Pharma to Report Fourth Quarter and Full Year 2017 Financial and Operating Results

01 Mar 2018
Antares Pharma Announces Receipt of Second Installment From Sale of ZOMAJET Needle-Free Delivery System

26 Feb 2018
Antares Pharma to Present at the Raymond James & Associates 39th Annual Institutional Investors Conference

15 Feb 2018
Antares Pharma Announces FDA Approval Of Partner's Product Utilizing Our Quickshot Auto Injector

16 Jan 2018
Antares Pharma Provides XYOSTED Regulatory Update

For Investors

Press Release Archive



Sign up for breaking news on ATRS

* indicates required